tanzania times : Latest News and In-depth Analysis
Contact Us
Search

Weekly

tanzania times : Latest News and In-depth Analysis
HomeWeekly
Weekly

Mar 18, 2025

Vantage Recognized with 'Best Global Broker' Award at Money Expo Mexico 2025

PORT VILA,Vanuatu,March 17,2025-- Vantage Markets participated as a Titanium Sponsor at Money Expo Mexico 2025,held on February 26-27. The event,known as one of the most significant gatherings for tr

All News

Weekly

Bangkok Dusit Medical Services and CNN joined forces to address global health challenges and explore next-gen solutions

HONG KONG,Feb. 10,2025-- BangkokDusit Medical Services Public Company Limited (BDMS),the largest private healthcare network in Thailand,has continued its long-term partnership with CNN International

Feb 11, 2025

Tuya Smart and Google Home APIs Fully Integrated: Building a Seamless Smart Home Ecosystem

NEW YORK,Feb. 10,2025-- Tuya Smart (NYSE: TUYA,HKEX: 2391),a global cloud platform service provider,recently announced the full integration of its smart ecosystem with Google Home APIs. This partnersh

Feb 11, 2025

Weekly

Boloni Opens Its First Experience Centre in Singapore

Setting new benchmarks in spatial design,Boloni\'s inaugural Experience Centre in Singapore highlights its innovative expertise,offering tailored solutions that blend luxury living with exceptional cr

Feb 10, 2025

Weekly

SANY Group Makes Historic Debut on the 2025 World's Top 500 Brands List

SHANGHAI,Feb. 8,2025-- SANY Group,a leading construction machinery manufacturer,has made history by securing the 468th position on the prestigious 2025 World\'s Top 500 Brands list,as revealed by the

Feb 10, 2025

Bravely Exploring New Pathways to Harness Future Energy: State Grid Changzhou Power Supply Company's Commitment to High-Quality Local Economic and Social Development

CHANGZHOU,China,Feb. 7,2025-- On February 5,theChangzhou Municipal Government convened the City Enterprise Development Conference,where State Grid Changzhou Power Supply Company was honored with the &

Feb 10, 2025

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Serplulimab is the world\'s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC

Feb 7, 2025

1 ... 66 67 68 69 70 71 72 ... 102